Results of the double-blind, randomized, multicenter, phase III clinical trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation

Osama O. Gaber, M. Roy First, Raymond J. Tesi, Robert S. Gaston, Robert Mendez, Laura L. Mulloy, Jimmy A. Light, Lillian W. Gaber, Elizabeth Squiers, Rodney J. Taylor, John F. Neylan, Robert W. Steiner, Stuart Knechtle, Douglas J. Norman, Fuad Shihab, Giacomo Basadonna, Daniel C. Brennan, Ernest E. Hodge, Barry D. Kahan, Lawrence KahanaSteven Steinberg, E. Steve Woodle, Laurence Chan, John M. Ham, Robert J. Stratta, Erik Wahlstrom, Kathleen R. Lamborn, H. Rossiter Horn, Hana Berger Moran, Philippe Pouletty, Timothy J. Schroeder

Research output: Contribution to journalArticle

212 Scopus citations

Fingerprint Dive into the research topics of 'Results of the double-blind, randomized, multicenter, phase III clinical trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences